NPI: 1174569909 · WALLINGFORD, CT 06492 · Clinical Medical Laboratory · NPI assigned 06/21/2006
Authorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
| Authorized Official | BOWLES, CHARLES (SR. VICE PRESIDENT) |
| Parent Organization | QUEST DIAGNOSTICS INCORPORATED |
| NPI Enumeration Date | 06/21/2006 |
Other providers sharing the same authorized official: BOWLES, CHARLES
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 80,889 | $88K |
| 2019 | 80,844 | $82K |
| 2020 | 81,091 | $83K |
| 2021 | 108,836 | $132K |
| 2022 | 139,604 | $130K |
| 2023 | 147,653 | $123K |
| 2024 | 109,072 | $68K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,961 | 1,702 | $133K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 40,770 | 34,300 | $60K |
| 85610 | 28,281 | 20,377 | $50K | |
| 84702 | 6,490 | 4,915 | $42K | |
| 88141 | 5,845 | 5,778 | $38K | |
| 36415 | Collection of venous blood by venipuncture | 56,131 | 39,937 | $38K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 22,310 | 13,765 | $20K |
| 85730 | 6,963 | 6,721 | $19K | |
| 83735 | 5,537 | 4,229 | $13K | |
| 82565 | 43,936 | 36,055 | $13K | |
| 81001 | 8,751 | 8,412 | $13K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 610 | 539 | $12K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 591 | 551 | $12K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 589 | 550 | $11K |
| 82247 | 31,692 | 27,946 | $11K | |
| 84520 | 43,392 | 35,621 | $10K | |
| 85027 | 8,281 | 7,144 | $10K | |
| 82310 | 42,314 | 34,677 | $10K | |
| 84295 | 42,677 | 34,933 | $10K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 450 | 367 | $9K |
| 87209 | 1,994 | 1,902 | $9K | |
| 84132 | 42,933 | 35,177 | $9K | |
| 82374 | 42,522 | 34,833 | $9K | |
| 88142 | 753 | 730 | $9K | |
| 82947 | 42,353 | 34,752 | $9K | |
| 82435 | 42,524 | 34,837 | $9K | |
| 84450 | 29,220 | 26,145 | $7K | |
| 82040 | 30,033 | 26,850 | $7K | |
| 84075 | 28,741 | 25,716 | $7K | |
| 84460 | 29,249 | 26,171 | $7K | |
| 87177 | 1,990 | 1,898 | $7K | |
| 82248 | 7,035 | 5,787 | $6K | |
| 84155 | 28,668 | 25,666 | $5K | |
| 84100 | 4,845 | 3,644 | $4K | |
| 80164 | 1,099 | 1,000 | $4K | |
| 81513 | 40 | 40 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 326 | 324 | $3K |
| 80053 | Comprehensive metabolic panel | 887 | 697 | $3K |
| 85652 | 2,784 | 2,301 | $3K | |
| 87510 | 237 | 161 | $3K | |
| 83690 | 985 | 882 | $3K | |
| 82670 | 351 | 236 | $3K | |
| 87660 | 205 | 161 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 537 | 496 | $2K |
| 87480 | 179 | 149 | $2K | |
| 85651 | 1,256 | 1,092 | $2K | |
| 85379 | 410 | 404 | $2K | |
| 80202 | 367 | 219 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 135 | 125 | $2K |
| 83880 | 768 | 624 | $2K | |
| 84144 | 329 | 213 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 56 | 55 | $2K |
| 80197 | 222 | 137 | $2K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 38 | 38 | $2K |
| 87088 | 334 | 317 | $2K | |
| 82150 | 428 | 372 | $1K | |
| 81003 | 949 | 885 | $1K | |
| 82977 | 585 | 549 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 56 | 55 | $1K |
| 86803 | 116 | 115 | $967.47 | |
| 80178 | 321 | 282 | $900.69 | |
| 83615 | 402 | 381 | $690.44 | |
| 84550 | 591 | 556 | $656.11 | |
| 87522 | Neg quan hep c or qual rna | 264 | 110 | $637.58 |
| 83002 | 112 | 84 | $605.82 | |
| 82550 | 182 | 169 | $534.03 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 105 | 102 | $434.29 |
| 84443 | Thyroid stimulating hormone (TSH) | 53 | 53 | $432.18 |
| 80050 | General health panel | 31 | 29 | $410.32 |
| 84146 | 112 | 102 | $405.82 | |
| 87070 | 102 | 96 | $403.30 | |
| 87077 | 82 | 79 | $373.76 | |
| 83001 | 53 | 43 | $366.98 | |
| 80061 | Lipid panel | 70 | 65 | $345.30 |
| 82570 | 112 | 102 | $299.75 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 13 | 13 | $235.02 |
| 87340 | 24 | 24 | $157.59 | |
| 84703 | 41 | 40 | $156.94 | |
| 85045 | 88 | 81 | $147.47 | |
| 82140 | 17 | 15 | $126.54 | |
| 88112 | 12 | 12 | $123.15 | |
| 84156 | 60 | 57 | $120.51 | |
| 82607 | 14 | 14 | $115.71 | |
| 87186 | 26 | 26 | $115.20 | |
| 85007 | 71 | 69 | $109.33 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 82 | 67 | $90.88 |
| 82728 | 12 | 12 | $82.94 | |
| 85018 | 70 | 67 | $51.50 | |
| 81025 | 13 | 12 | $45.33 | |
| 86592 | 17 | 17 | $44.21 | |
| 85014 | 53 | 51 | $36.87 | |
| 36416 | 674 | 540 | $0.00 |